Clinical Trial

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

Name: Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells — clinical trial record (NCT03628612)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 2

View on ClinicalTrials.gov →

Summary

Long-term follow-up of patients exposed to an AUTO CAR T cell therapy for up to 15 years following their first AUTO CAR T cell therapy infusion.

Protocol Amendment History 8 amendments

This ClinicalTrials.gov record has been amended 8 times since 2018-08-09; most recent amendment 2025-08-04.

Trial Details

NCT Number	NCT03628612
Lead Sponsor	Autolus Limited
Conditions	Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy, Multiple Myeloma, DLBCL, ALL, Adult and Pediatric, T Cell Lymphoma
Enrollment	500 participants
Start Date	2018-08-02
Primary Completion	2043-07 (estimated)
Study Completion	2043-12 (estimated)
Updated on ClinicalTrials.gov	2025-08-07